SFSeyedeh Tahereh Faezi

Seyedeh Tahereh Faezi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seyedeh Tahereh Faezi has a total of 181 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Takayasu arteritis presenting with dysphagia and morning stiffness: a diagnostic challenge in a middle-aged woman

    by Niloofar Najafi, Seyedeh Tahereh Faezi, Hakimeh Sadeghian, Khashayar Danandeh

    Background: Takayasu arteritis is a rare, chronic vasculitis affecting large arteries, primarily the aorta and its principal branches. The illness frequently presents with non-specific systemic symptoms, leading to a postponed diagnosis. Dysphagia resulting from aortic involvement is a rare manifestation and may resemble other cardiovascular or gastrointestinal disorders. Case presentation: We report a 45-year-old Iranian woman with a one-year history of exertional dyspnoea, intermittent dysphagia for solid food, and diffuse musculoskeletal pain with morning stiffness. Initial evaluation showed elevated inflammatory markers, moderate aortic regurgitation, and aneurysmal dilation of the ascending aorta and aortic arch, and infective endocarditis was initially suspected. After serial negative blood cultures and resolution of a suspicious valvular finding on repeat transoesophageal echocardiography, upper gastrointestinal endoscopy and endoscopic ultrasonography localised her dysphagia to extrinsic oesophageal compression by the dilated thoracic aorta. Computed tomography angiography confirmed a non-dissecting aneurysm of the ascending aorta and arch, and whole-body ¹⁸F-FDG PET demonstrated markedly increased metabolic activity along the thoracic aorta and its supra-aortic branches, consistent with active large-vessel vasculitis. After systematic exclusion of infective and other inflammatory mimics, a clinical diagnosis of Takayasu arteritis was made. Conclusion: This case illustrates an uncommon presentation of Takayasu arteritis with dysphagia produced by extrinsic oesophageal compression from thoracic aortic aneurysmal dilatation. Constitutional symptoms, elevated inflammatory markers, and unexplained cardiovascular findings should prompt evaluation for large-vessel vasculitis. Early multimodal imaging and a systematic approach to excluding infective and other inflammatory mimics are essential for accurate diagnosis and timely treatment.

  • Open Access

    Ultrasound findings and clinical evaluation of temporomandibular joint involvement in systemic lupus erythematosus and Sjögren’s syndrome: A cross-sectional study

    by Somayeh Soroureddin, Ahmadreza Jamshidi, Omid Ghaemi, Tahereh Faezi, Ali Baradaran Bagheri, Majid Alikhani

    This study aimed to evaluate temporomandibular joint (TMJ) involvement in patients with systemic lupus erythematosus (SLE) and Sjögren’s syndrome, using clinical assessment and ultrasound (US) imaging. A cross-sectional study was conducted involving 51 patients (41 with SLE and 10 with Sjögren’s syndrome). TMJ dysfunction was assessed using clinical examination and US. Statistical analyses compared clinical and ultrasound findings and explored associations with disease characteristics. TMJ abnormalities were detected in 57% by US and 39% by clinical examination. Cortical irregularities (46% in SLE, 60% in Sjögren’s syndrome) and osteophyte formation (29% in SLE and 30% in Sjögren’s syndrome) were the most common US findings. Joint effusion was observed in 9.8% of patients with SLE but was absent in those with Sjögren’s syndrome. Clinical symptoms, such as TMJ pain (7.3%), tenderness (2.4%), and joint clicking (4.9%), were reported only in patients with SLE. Jaw deviation was the most frequent clinical finding (26.8% in SLE and 30% in Sjögren’s syndrome). TMJ abnormalities were more frequently detected via US than by clinical examination, particularly in Sjögren’s syndrome (70% vs 30%, P < .05). TMJ involvement is prevalent in both SLE and Sjögren’s syndrome, with US detecting abnormalities at a higher rate than clinical examinations. These findings highlight the importance of US in early TMJ assessment, supporting its role as a valuable screening tool for rheumatic disease management. Further research is required to explore the clinical implications and disease-specific patterns of TMJ involvement.

  • Open Access

    Developing a Core Outcome Set for Prognosis of Hip Osteonecrosis in Iranian Population: A Multimethod Study

    by Seyedeh Tahereh Faezi, Seyyed Amir Yasin Ahmadi, Niusha Mokhtarbaf, Mitra Elmi, Arash Tehrani-Banihashemi

    Introduction: Core outcome set (COS) is a consensus‐based set of outcomes derived from a multimethod technique. The present study aimed to develop a COS for prognosis of hip osteonecrosis in response to treatment which was suitable for Iranian patients, and we performed stakeholder analysis. Methods: This multimethod study was conducted in the following phases: (1) extraction of outcomes through an umbrella review of the previous meta‐analyses, (2) expert panel survey, (3) qualitative interview with patients, and (4) compilation of the COS with the help of triangulation of study phases. Results: The umbrella review was performed on 34 documents. The outcomes were generally classified into several categories including clinical, radiological, and surgical outcomes. In the second phase, the expert panel proposed the outcomes as time to return to work, time to return to daily activity, joint range of motion, improvement in walking, bone swelling, weight bearing, extent of necrosis, conversion to total hip arthroplasty (THA), pain reduction, improvement in hygiene, and improvement in function. In the third phase, patients mainly complained of joint stiffness, and this was the first outcome that reached saturation in the interview. Finally, the COS was presented. Conclusion: The main focus was on the clinical outcomes, which were prioritized in the triangulation of the methods and the opinion of the stakeholders. Patients are looking for their movement problems and limitations to be corrected as soon as possible and to return to their daily activities. The final COS of this study for clinical use includes pain, joint range of motion and lack of stiffness, improvement in function, ability to walk, and return to daily activity.

  • Open Access

    Effect of Self‐Care on Temporomandibular Disorder in Drug‐Controlled Rheumatoid Arthritis Patients

    by Hosna Bahrami, Seyedeh Tahereh Faezi, Mahdieh-Sadat Moosavi

    Objectives: Temporomandibular disorders (TMDs) in patients with rheumatoid arthritis (RA) can lead to orofacial pain and dysfunction of the temporomandibular joint (TMJ). Self‐care is a recognized primary intervention for controlling TMDs, offering a simple reversible treatment, since there is no specific treatment protocol for TMDs in RA patients. This study aims to investigate the effectiveness of self‐management in improving TMD symptoms in RA patients under drug control. Methods: This prospective Phase II clinical trial included 64 drug‐controlled RA patients presenting with signs or symptoms of TMDs. All participants underwent baseline assessment using the RDC/TMD questionnaire, Numerical Analog Scale (NAS), and Helkimo Index, followed by a standardized clinical evaluation of jaw function and muscle/joint tenderness. Patients received structured self‐care education, including bilateral chewing exercises, mouth‐opening limitation within pain threshold, dietary modification, thermal modalities, parafunctional habit control, and therapeutic massage. Reminder messages and follow‐up phone calls were provided to reinforce adherence. Clinical examinations were repeated after 2 months to evaluate changes in pain intensity, jaw mobility, joint sounds, and TMD severity. Results: Ultimately, reductions in TMD severity based on the Helkimo criteria and patient self‐report using the NAS, as well as reductions in the number of painful muscles and joints, improvement in maximum mouth opening, lateral and protrusive movements, and decreased jaw sounds were observed in patients. Conclusions: Adherence to self‐management as the main component of treatment can be a highly effective, sustainable, and side‐effect‐free approach for managing symptomatic TMD in patients with RA. Clinical Significance: Self‐care significantly reduced TMD pain, improved mouth movements, and decreased jaw sounds in RA patients with TMJ involvement. Trial Registration: Iranian Registry of Clinical Trials: IRCT N120221113056489

  • Open Access

    Drooling as a Red Flag: Insights From a Case Series in Severe Dermatomyositis With Literature Review

    by Alireza Mirzamohamadi, Shokufe Sadeghi, Yalda Nilipour, Somayeh Motamed, Vahid Ardestani Rostami, Ahmadreza Jamshidi, Masoomeh Akhlaghi, Hoda Kavoosi, Majid Alikhani, Seyedeh Tahereh Faezi

    Dermatomyositis (DM) is a rare idiopathic inflammatory disease characterized by progressive proximal muscle weakness and distinctive dermatologic manifestations. Although dysphagia is a recognized complication of oropharyngeal muscle involvement, drooling (sialorrhea) is infrequently described and may be a marker of severe disease. This case series reports three adult patients with severe DM who presented with drooling, highlighting diagnostic challenges and therapeutic dilemmas in the management of refractory disease. All patients in the present study exhibited severe DM with prominent dysphagia, leading to drooling. Despite intensive immunosuppressive therapy, including high‐dose corticosteroids, immunosuppressants, intravenous immunoglobulin, and Rituximab, the outcome was disappointing, highlighting the refractory nature of the disease. The patients experienced readmissions following the worsening of dysphagia and drooling, which eventually led to complications like aspiration pneumonia and sepsis and ultimately fatal outcomes. Anti‐Ro52 and Anti‐Nuclear Matrix Protein 2 (NXP2) antibodies correlated with a more severe disease course and poor prognosis. Although rare, drooling in DM may be a clinical marker of severe DM with extensive oropharyngeal involvement and an increased risk for life‐threatening complications. Early evaluation and initiation of intensive combination therapy could improve patient outcomes. Further research is needed to refine treatment protocols for this challenging manifestation of DM patients.

  • Open Access

    Clinical features and chronology of clinical manifestations in Behçet’s disease: A cohort of 2615 patients

    by Shokufe Sadeghi, Seyedeh Tahereh Faezi, Hoda Haerian, Mohammad Nejadhosseinian, Azarakhsh Baghdadi, Farhad Shahram, Massoomeh Akhlaghi, Majid Alikhani, Gilava Hedayati Emam, Fereydoun Davatchi

    Introduction: Behçet’s disease (BD) presents with highly variable clinical manifestations and a hete­rogeneous pattern of symptom development. This study aimed to assess the chronology of symptom onset and clinical findings in BD patients at a nationally recognized Behçet’s referral center and to examine associations between symptom progression and patient- and disease-related characteristics. Material and methods: A retrospective review of BD patients from a national referral center in Iran was conducted between March 2007 and March 2017. Patients with ≥ 2 years of follow-up were included. Demographic data, clinical characteristics, and laboratory findings were extracted. The initial symptom and the sequence of symptom development were analyzed. The time between symptom onset and diagnosis was recorded, and comparisons were made based on sex, age, human leukocyte antigen (HLA) type, and initial presenting symptom. Results: A total of 2,615 patients (58.7% male) were included. The mean age at BD diagnosis was 25.0 ±10.1 years, with a median follow-up of 26 years. Oral ulcers were the most common manifestation (98.9% overall) and the most frequent initial symptom (90.3%). Genital ulcers were observed in 61.3% of patients, with a mean onset 4.6 ±5.7 years after diagnosis. Ocular and vascular manifestations had the longest latency from diagnosis. Male patients had a shorter time to onset of oral ulcers (p = 0.04) and ocular lesions (p = 0.04). Age correlated inversely with the time to onset of genital ulcers, skin, ocular, and vascular manifestations (all p < 0.001). The HLA-B5/B51 carriers exhibited an earlier onset of genital ulcers (p = 0.004) and skin manifestations (p = 0.04). Conclusions: Our findings highlight substantial temporal heterogeneity in BD symptom progression. While oral ulcers appear early, genital ulcers and skin manifestations tend to develop later, and ocular and vascular lesions exhibit the longest delay. The chronology of symptom onset is significantly influenced by age, sex, HLA-B5/B51 status, and initial presenting symptom. These findings underscore the importance of long-term follow-up in BD management.


  • Open Access

    Effect of writing based on self-compassion on body image and psychological distress among women with systemic lupus erythematosus: a randomized clinical trial

    by Kimya Amouei, Arpi Manookian, Seyedeh Tahereh Faezi, Leila Sayadi

    Women with systemic lupus erythematosus (SLE) are at risk for body image (BI) disturbances and its resultant psychological distress (PD). The aim of this study was to examine the effects of self-compassion (SC)-based writing on BI and PD among women with SLE. In this randomized clinical trial, which was done in 2022–2023, 86 women with SLE were selected and randomly allocated to an intervention group (IG) and a control group (CG). Participants in the IG were instructed to engage in SC-based writing that emphasized the concepts of common humanity, mindfulness, and self-kindness. Six blank pages were provided, each featuring a question related to self-compassion for participants to address. Conversely, the CG was also provided with papers and asked to respond to questions that were unrelated to SC. Data were collected before, immediately after, and one month after the intervention (T1–T3) using a demographic and clinical characteristics questionnaire, the SLE Disease Activity Index, the Body Image Lupus Scale(BILS), the Depression Anxiety Stress Scale, the Self-Compassion Scale, and the Body Image Quality of Life Inventory(BIQLI). The SPSS software (v. 22.0) was employed for data analysis. Groups did not significantly differ from each other respecting baseline demographic and clinical characteristics and baseline mean scores of the main study outcomes. However, there were significant between-group differences respecting the mean scores of BI (P = 0.028), stress (P = 0.003), anxiety (P = 0.003), and SC (P < 0.001) at T2 and the mean scores of stress (P = 0.023), anxiety (P = 0.029), and SC (P < 0.001) at T3. Moreover, between-group differences respecting the other study outcomes at T2 and T3 were insignificant (P > 0.05). SC-based writing significantly increases SC among women with SLE. Patients may be encouraged to engage in SC-based writing through education about this technique. Investigating alternative strategies or implementing the intervention at different time intervals may be beneficial for improving the BILS, PD, and BIQLI. This study was registered in the Iranian Registry of Clinical Trials in February 14, 2022 (code: IRCT20220107053656N1).

  • The Effect of Probiotic Yogurt Containing Lactobacillus rhamnosus and Bifidobacterium bifidum on Disease Activity and Disability in Patients with Systemic Lupus Erythematosus: A Randomized Controlled Trial

    by Razieh Banaki, Seyedeh Tahereh Faezi, Ahmad Esmaeilzadeh, Mahdi Mahmoudi, Elham Farhadi, Majid Alikhani

    Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease with relapsing and remitting periods. It has been reported that alterations of gut microbiota can affect disease activity in SLE. Probiotics which can modify the gut microbiota may be useful to control disease activity. Therefore, the effect of probiotic yogurt was evaluated on SLE disease activity. In this triple-blind, randomized, controlled trial, the patients were randomized and divided into 2 groups. The patients had Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) ≤6 and were on a stable dose of immunosuppressant in the last 3 months. The intervention group was given 200 g of probiotic yogurt containing Lactobacillus rhamnosus and Bifidobacterium bifidum for 13 weeks. The control group was given 200 g of yogurt without bacteria for 13 weeks. Demographic measurements, SLEDAI, and Health Assessment Questionnaire (HAQ) were analyzed before and after the intervention. The probiotic group (19 patients) and the control group (14 individuals) were compared. At the beginning and baseline of the trial, the probiotic and control groups’ average energy intake, micronutrients, and macronutrients did not differ significantly. In the probiotic group, the amount of protein, cholesterol, magnesium, zinc, selenium, and iron intake increased significantly after intervention. There are no significant changes in SLEDAI score and disability (HAQ) between case and control groups at the end of the study. Consumption of probiotic yogurt containing L. rhamnosus and B. bifidum did not have a significant short-term effect on SLEDAI and disability in SLE patients.


  • Open Access

    Asymptomatic multifocal avascular necrosis, a commonly overlooked finding in patients with systemic lupus erythematosus

    by Forough Nadi, Esmat Abdollahpour, Babak Fallahi, Leila Aghaghazvini, Majid Alikhani, Mohammad Nejadhosseinian, Seyedeh Tahereh Faezi

    BackgroundIn patients with Systemic lupus erythematosus (SLE), osteonecrosis of various joints is a debilitating complication associated with the disease and its treatment, in which a considerable proportion of osteonecrosis may be asymptomatic. Recognizing the crucial role of early and timely detection, as well as appropriate management of asymptomatic osteonecrosis, in preventing joint destruction, we conducted a study to evaluate the prevalence of asymptomatic osteonecrosis in SLE patients who have already been diagnosed with symptomatic osteonecrosis. Additionally, we aimed to examine the relationship between proposed risk factors of osteonecrosis and the development of asymptomatic osteonecrosis.MethodsIn this cross-sectional study, Patients with recently diagnosed symptomatic osteonecrosis of at least one joint were selected by reviewing data from the digital medical record system of the Rheumatology Research Center. The patients underwent three-phase Single Photon Emission Computed Tomography (SPECT) bone scintigraphy to screen for other asymptomatic osteonecrotic joints. MRI was subsequently performed on the asymptomatic osteonecrotic sites for further diagnostic confirmation. The study evaluated the prevalence of asymptomatic osteonecrosis, the extent of joint involvement, the specific locations of osteonecrosis, the most commonly affected joints, and the risk factors for asymptomatic osteonecrosis.ResultsEight out of the 17 patients (47%) who participated in our research were found to have asymptomatic osteonecrosis. The most commonly affected joint without symptoms was the left knee (25%), while the most frequently affected joint with symptoms was the left hip (23.07%). The only statistically significant difference observed between patients with and without asymptomatic osteonecrosis in this study was the age at which the disease first appeared (p = 0.046) and this age was higher among patients with asymptomatic osteonecrosis.ConclusionsOur research provides further evidence of the high incidence of asymptomatic osteonecrosis in individuals with SLE due to the nature of the disease and the frequent use of high-dose corticosteroids. It underscores the importance of early detection through whole-body SPECT bone scintigraphy and MRI, as well as prompt intervention in order to avert the incapacitating effects of osteonecrosis.


  • Open Access

    Evaluation of core decompression outcome in systemic lupus erythematosus with hip osteonecrosis: a retrospective cohort study

    by Pouya Hadighi, Seyedeh Tahereh Faezi, Seyed Mohammad Javad Mortazavi, Mohsen Rokni, Leila Aghaghazvini, Amir Kasaeian, Mohammad Nejadhosseinian, Hoda Haerian, Hamid Reza Fateh

    Background: Osteonecrosis is a major cause of morbidity for patients with systemic lupus erythematosus (SLE). Although core decompression is an approved and trusted technique to prevent further joint deterioration, this surgical method seems to be less beneficial for SLE patients. We aimed to evaluate the outcomes of core decompression in SLE patients with primary stages of femoral head osteonecrosis. Methods: In this study, 23 patients (39 affected hip joints) with osteonecrosis of the femoral head with stage II of the disease, based on the Ficat-Arlet classification system, underwent core decompression. Also, patients demographic characteristics, clinical data, medication history, comorbidities, immunological findings, hip plain radiographs, history of total hip arthroplasty after core decompression, and patients satisfaction with joint function according to the Oxford hip score questionnaire were obtained. Results: In the study, 53.8% of affected joints showed signs of radiographic deterioration in follow-up imaging. Sixty-one and a half percent (61.5%) of patients had unsatisfactory joint performance. A third (33.3%) of affected hip joints underwent total hip arthroplasty up to 5 years from core decompression. SLE patients with a history of receiving bisphosphonate were 83.2% less dissatisfied with their joint function than patients without a history of bisphosphonate use (P < 0.02). Of the 23 studied cases, the mean cumulative dose of prednisolone before and after core decompression surgery was 46.41 mg and 14.74 mg respectively. Besides, one case (2.6%) that had a high anti-phospholipid antibodies level during follow-up did not have any radiographic deterioration, and 9 cases (23.1%) had some degrees of radiographic deterioration. Conclusions: The patients group that used bis-phosphonate, had a higher level of satisfaction with joint function after core decompression. Patients with high-level anti-phospholipid antibodies are related to a poor prognosis after core decompression.